Enjoy complimentary customisation on priority with our Enterprise License!
The gamma-butyrolactone market size is forecast to increase by USD 741.1 million at a CAGR of 5.9% between 2023 and 2028.
The gamma-butyrolactone industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The dehydrogenation of 1 4 butanediol segment is estimated to witness significant growth during the forecast period.
The dehydrogenation of 1,4-butanediol is a crucial process in organic chemistry, resulting in the production of gamma-butyrolactone (GBL). This compound, synthesized from 1,4-butanediol, is employed extensively in the manufacturing of polymers, solvents, and other chemicals. The generation of GBL involves heating 1,4-butanediol under atmospheric pressure and temperatures ranging from 180°C to 300°C, in the presence of a copper catalyst. This process yields approximately 95% of GBL, which is subsequently purified using liquid-gas phase extraction. The global market for gamma-butyrolactone exhibits significant growth due to its wide application in various industries. For instance, GBL is a vital component in the production of lithium-ion batteries used in electronics and electric vehicles.
Moreover, it serves as a high-purity solvent in the manufacturing of capacitors and an anesthetic agent in the medical field. However, the production and utilization of GBL pose potential health risks. Consumption of GBL can lead to adverse effects such as confusion, drowsiness, coma, ataxia, hypersalivation, and tremor. Additionally, prolonged exposure to GBL may result in metabolic acidosis, hypotension, respiratory depression, agitation, gastrointestinal disturbances, bradycardia, sedatives, headache, insomnia, urinary incontinence, hypokalaemia, hypernatraemia, hypersalivation, myoclonus, and withdrawal syndrome. Despite these challenges, the demand for GBL remains strong due to its essential role in the sustainable society's development. The ongoing research and development efforts aim to minimize the health risks associated with its production and usage, ensuring the continued growth of the market.
The production of GBL occurs primarily in Okayama Prefecture, Japan, at the Okayama Plant in Kurashiki City. This facility is a significant contributor to the domestic market, which experiences continuous growth due to the increasing demand for GBL in various industries. In summary, the dehydrogenation of 1,4-butanediol leads to the production of gamma-butyrolactone, a versatile compound with extensive applications in various industries. Despite potential health risks, the market for GBL is expected to grow due to its importance in the sustainable society's development and ongoing research efforts to mitigate the associated risks.
Get a glance at the market report of share of various segments Request Free Sample
The Dehydrogenation of 1 4 butanediol segment was valued at USD 1015.80 million in 2018 and showed a gradual increase during the forecast period.
APAC is estimated to contribute 64% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market size of various regions, Request Free Sample
Gamma-butyrolactone (GBL), a high-purity solvent, is a significant player in various industries, including agrochemicals, pharmaceuticals, and electronics. In 2023, APAC held over 50% of the global market share. China and India, as major contributors, fueled the regional growth. China's dominance is due to the presence of leading companies and the expansion of end-user industries. GBL's versatility lies in its application across different industries and purity levels. Commercial-grade GBL is utilized in herbicides for agricultural applications. Conversely, high-purity GBL is essential for pharmaceuticals and textiles. However, the use of GBL comes with potential health risks, such as Confusion, Drowsiness, Ataxia, Coma, Withdrawal syndrome, Hypersalivation, Toxicity, and Dependence.
These risks are associated with overexposure or misuse, leading to conditions like Hypernatraemia, Hyperglycaemia, Hypokalaemia, Hypotension, Respiratory depression, Agitation, Gastrointestinal disturbances, Bradycardia, Sedatives, Headache, Insomnia, Urinary incontinence, Hypotension, and Hypersalivation. Moreover, GBL is an anesthetic agent and is used in the production of lithium-ion batteries, capacitors, and sedatives. Its application in the electronics industry, particularly in the production of EVs (electric vehicles), is on the rise due to the sustainable society's growing emphasis on reducing carbon emissions. However, the production process requires careful handling to prevent metabolic acidosis, Dose escalation, and Vomiting. The Okayama Plant in Kurashiki City, Okayama Prefecture, Japan, is a notable producer of GBL.
The plant's high production capacity contributes significantly to the domestic market. Despite these advancements, it is crucial to address the health risks associated with GBL to ensure safe and responsible usage.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The gamma-butyrolactone market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the gamma-butyrolactone market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, gamma-butyrolactone market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Ashland Inc. - The company introduces gamma butyrolactone under the brand name Blo, showcasing its commitment to delivering innovative chemical solutions. This compound, a gamma-hydroxy alpha-butyrolactone, is a versatile chemical used in various industries, including pharmaceuticals and agriculture. Its unique properties offer potential applications in solvents, intermediates, and synthesis processes. By introducing Blo, the company underscores its dedication to advancing chemical technology and contributing to industry progress.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Gamma-butyrolactone (GBL), a high-purity solvent with a unique chemical structure, has been gaining significant attention in various industries due to its versatile applications. This organic compound, characterized by its distinct odor and viscous nature, has been utilized as a raw material in the production of various chemicals and consumer products. The global market for GBL is witnessing growth, driven by the increasing demand from the electronics industries, particularly in the manufacturing of lithium-ion batteries. The demand for these batteries is surging due to the growing popularity of electric vehicles (EVs) and the shift towards a sustainable society.
However, the use of GBL is not without its challenges. The compound is known to cause several health issues, including confusion, drowsiness, and in extreme cases, coma, hypernatraemia, and hypoglycaemia. These conditions can lead to withdrawal syndrome, ataxia, hypotension, respiratory depression, agitation, gastrointestinal disturbances, bradycardia, sedatives, headache, insomnia, urinary incontinence, hypersalivation, and tremor. Despite these health concerns, the domestic market for GBL remains strong due to its extensive use as a solvent in various industries. In Kurashiki City, Okayama Prefecture, Japan, there is an Okayama plant that specializes in the production of high-purity GBL. This plant has a significant production capacity, catering to both domestic and international demand.
The use of GBL as an anesthetic agent and sedative is another significant application area. However, its toxicity and potential for dependence have raised concerns among regulatory bodies and healthcare professionals. The compound can cause metabolic acidosis, vomiting, and dose escalation, leading to severe health complications. Despite these challenges, the market for GBL is expected to continue its growth trajectory, driven by the increasing demand from various industries. The compound's unique properties make it an indispensable ingredient in the production of capacitors, solvents, and other chemicals. As the world continues to transition towards a sustainable and electric future, the demand for GBL is expected to remain strong.
In , the market for GBL is a dynamic and evolving one, characterized by its versatile applications and unique properties. While the compound offers numerous benefits, its potential health risks cannot be ignored. As the industry continues to grow, it is essential to prioritize safety measures and regulatory compliance to mitigate the risks associated with GBL use.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
136 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.9% |
|
Market growth 2024-2028 |
USD 741.1 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
5.5 |
|
Key countries |
China, US, Germany, France, and India |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this gamma-butyrolactone market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
